Form 4: Chemed Corp Director Acquires Shares

Ron DeLyons, a Director at Chemed Corp, reported the acquisition of 386 shares of company stock on May 18, 2026.

Summary

• Ron DeLyons, a Director of Chemed Corp, acquired 386 shares of the company's capital stock on May 18, 2026.
• The transaction was executed at a price of $440.77 per share.
• Following this acquisition, DeLyons beneficially owns 2,052 shares of Chemed Corp stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine insider transaction without providing new financial or strategic information.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The purchase was made at a specific price, indicating a defined market valuation at the time of the transaction.

Future Outlook

No forward-looking statements or guidance are present in this filing.

Industry Context

StockSavvy.ai notes that insider transactions, such as this share acquisition by a director, are closely watched by the market as potential indicators of management's view on the company's valuation and future performance.

Stakeholder Impact

• Shareholders may view the director's purchase as a positive signal of confidence in the company's value.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Chemed Corp, CHE, Director Transaction, Share Acquisition, Beneficial Ownership